Warfarin sensitivity
Last updated 19 Sept 2024
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
Warfarin sensitivity is a condition in which individuals have a low tolerance for the drug warfarin. Warfarin is an anticoagulant, which means that it thins the blood, preventing blood clots from forming. Warfarin is often prescribed to prevent blood clots in people with heart valve disease who have replacement heart valves, people with an irregular heart beat (atrial fibrillation), or those with a history of heart attack, stroke, or a prior blood clot in the deep veins of the arms or legs (deep vein thrombosis).
Video picks for Genetic conditionsVideo library
Description
Warfarin sensitivity is a condition in which individuals have a low tolerance for the drug warfarin. Warfarin is an anticoagulant, which means that it thins the blood, preventing blood clots from forming. Warfarin is often prescribed to prevent blood clots in people with heart valve disease who have replacement heart valves, people with an irregular heart beat (atrial fibrillation), or those with a history of heart attack, stroke, or a prior blood clot in the deep veins of the arms or legs (deep vein thrombosis).
Many people with warfarin sensitivity take longer than normal to break down (metabolize) warfarin. The medication remains active in their body longer than usual, so they require lower doses. These individuals are classified as "slow metabolizers" of warfarin. Other people with warfarin sensitivity do not need as much drug to prevent clots because their clot-forming process is naturally slower than average and can be stopped by low warfarin doses. If people with warfarin sensitivity take the average dose (or more) of warfarin, they are at risk of an overdose, which can cause abnormal bleeding in the brain, gastrointestinal tract, or other tissues, and may lead to serious health problems or death.
Warfarin sensitivity does not appear to cause any health problems other than those associated with warfarin drug treatment.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal dominant. More than one pattern can apply in different cases.
Related genes
Other names
Coumadin sensitivity
Warfarin response
Patient picks for Genetic conditions

Drug interactions checker
Can I take Warfarin and Paracetamol together?
Taking paracetamol regularly or in high doses while on warfarin can increase your risk of bleeding. While an occasional single dose of paracetamol is usually safe, taking it daily for several days can make your blood thinner than intended.

Drug interactions checker
Can I take Warfarin and Methotrexate together?
Taking methotrexate while on warfarin can significantly increase your risk of bleeding. This might show up as unusual bruising, nosebleeds, bleeding gums, or in more serious cases, internal bleeding. It can also cause your blood-clotting tests (INR) to become unstable.

Drug interactions checker
Can I take Magnesium and Warfarin together?
Taking magnesium supplements at the same time as warfarin may slightly reduce how well warfarin works. This could potentially make your blood more likely to clot than intended.

Drug interactions checker
Can I take Warfarin and Aspirin together?
Taking warfarin and aspirin together significantly increases your risk of serious bleeding. This includes internal bleeding, such as in the stomach or brain, as well as bleeding that is hard to stop from minor cuts or injuries.

Drug interactions checker
Can I take Warfarin and Ibuprofen together?
Taking ibuprofen while on warfarin significantly increases your risk of serious bleeding, particularly in the stomach or gut. This combination can cause internal bleeding that may be difficult to stop.

Drug interactions checker
Can I take Warfarin and Amoxicillin together?
Taking amoxicillin while on warfarin can increase the risk of bleeding. You might notice that your blood takes longer to clot, or you may experience unusual bruising or nosebleeds.
Related patient information and medicines

Patient information leaflet
Can I take Glucosamine and St John's wort together?
Diabe... You should monitor your blood sugar more closely when starting or changing your dose. Taking Warfarin (blood thinner) Glucosamine can significantly increase the blood-thinning effect of warfarin, which increases your risk of serious bleeding. Do not take glucosamine with warfarin unless specifically monitored by your doctor. Depression.

Patient information leaflet
Can I take St John's wort and Vitamin C together?
Seek immediate medical help if your mood worsens. Drug Interactions St John's wort significantly reduces the effectiveness of many essential medicines, including the contraceptive pill, blood thinners (warfarin), epilepsy medications, and organ transplant drugs. Do not start it without a pharmacist checking your current medications. Serotonin.

Patient information leaflet
Can I take St John's wort and Vitamin B12 together?
Seek immediate medical help if your mood worsens. Drug Interactions St John's wort significantly reduces the effectiveness of many essential medicines, including the contraceptive pill, blood thinners (warfarin), epilepsy medications, and organ transplant drugs. Do not start it without a pharmacist checking your current medications. Serotonin.

Patient information leaflet
Can I take St John's wort and Sertraline together?
Increased bleeding risk Sertraline can increase the risk of bleeding, especially if you are taking other medicines that affect blood clotting, such as aspirin, ibuprofen (NSAIDs), or warfarin. Seek medical advice if you notice unusual bruising or bleeding. Drug Interactions St John's wort makes many essential medicines less effective, including.

Patient information leaflet
Can I take St John's wort and Vitamin B2 together?
Seek immediate medical help if your mood worsens. Drug Interactions St John's wort significantly reduces the effectiveness of many essential medicines, including the contraceptive pill, blood thinners (warfarin), epilepsy medications, and organ transplant drugs. Do not start it without a pharmacist checking your current medications. Serotonin.

Patient information leaflet
Can I take Folic acid and St John's wort together?
Seek immediate medical help if your mood worsens. Drug Interactions St John's wort significantly reduces the effectiveness of many essential medicines, including the contraceptive pill, blood thinners (warfarin), epilepsy medications, and organ transplant drugs. Do not start it without a pharmacist checking your current medications. Serotonin.
Further reading and references
- Warfarin sensitivity; MedlinePlus, National Library of Medicine.
- Deng J, Vozmediano V, Rodriguez M, Cavallari LH, Schmidt S. Genotype-guided dosing of warfarin through modeling and simulation. Eur J Pharm Sci. 2017 Nov 15;109S:S9-S14. doi: 10.1016/j.ejps.2017.05.017. Epub 2017 May 11.
- Ferder NS, Eby CS, Deych E, Harris JK, Ridker PM, Milligan PE, Goldhaber SZ, King CR, Giri T, McLeod HL, Glynn RJ, Gage BF. Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy. J Thromb Haemost. 2010 Jan;8(1):95-100. doi: 10.1111/j.1538-7836.2009.03677.x. Epub 2009 Oct 30.
- Flockhart DA, O'Kane D, Williams MS, Watson MS, Flockhart DA, Gage B, Gandolfi R, King R, Lyon E, Nussbaum R, O'Kane D, Schulman K, Veenstra D, Williams MS, Watson MS; ACMG Working Group on Pharmacogenetic Testing of CYP2C9, VKORC1 Alleles for Warfarin Use. Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin. Genet Med. 2008 Feb;10(2):139-50. doi: 10.1097/GIM.0b013e318163c35f.
- Johnson JA, Caudle KE, Gong L, Whirl-Carrillo M, Stein CM, Scott SA, Lee MT, Gage BF, Kimmel SE, Perera MA, Anderson JL, Pirmohamed M, Klein TE, Limdi NA, Cavallari LH, Wadelius M. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update. Clin Pharmacol Ther. 2017 Sep;102(3):397-404. doi: 10.1002/cpt.668. Epub 2017 Apr 4.
- Johnson JA, Gong L, Whirl-Carrillo M, Gage BF, Scott SA, Stein CM, Anderson JL, Kimmel SE, Lee MT, Pirmohamed M, Wadelius M, Klein TE, Altman RB; Clinical Pharmacogenetics Implementation Consortium. Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clin Pharmacol Ther. 2011 Oct;90(4):625-9. doi: 10.1038/clpt.2011.185. Epub 2011 Sep 7.
- Kaye JB, Schultz LE, Steiner HE, Kittles RA, Cavallari LH, Karnes JH. Warfarin Pharmacogenomics in Diverse Populations. Pharmacotherapy. 2017 Sep;37(9):1150-1163. doi: 10.1002/phar.1982. Epub 2017 Sep 6.
- Krishna Kumar D, Shewade DG, Loriot MA, Beaune P, Balachander J, Sai Chandran BV, Adithan C. Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population. Eur J Clin Pharmacol. 2014 Jan;70(1):47-56. doi: 10.1007/s00228-013-1581-x. Epub 2013 Sep 10.
- Moyer TP, O'Kane DJ, Baudhuin LM, Wiley CL, Fortini A, Fisher PK, Dupras DM, Chaudhry R, Thapa P, Zinsmeister AR, Heit JA. Warfarin sensitivity genotyping: a review of the literature and summary of patient experience. Mayo Clin Proc. 2009 Dec;84(12):1079-94. doi: 10.4065/mcp.2009.0278.
- Perera MA, Cavallari LH, Limdi NA, Gamazon ER, Konkashbaev A, Daneshjou R, Pluzhnikov A, Crawford DC, Wang J, Liu N, Tatonetti N, Bourgeois S, Takahashi H, Bradford Y, Burkley BM, Desnick RJ, Halperin JL, Khalifa SI, Langaee TY, Lubitz SA, Nutescu EA, Oetjens M, Shahin MH, Patel SR, Sagreiya H, Tector M, Weck KE, Rieder MJ, Scott SA, Wu AH, Burmester JK, Wadelius M, Deloukas P, Wagner MJ, Mushiroda T, Kubo M, Roden DM, Cox NJ, Altman RB, Klein TE, Nakamura Y, Johnson JA. Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study. Lancet. 2013 Aug 31;382(9894):790-6. doi: 10.1016/S0140-6736(13)60681-9. Epub 2013 Jun 5.
- Saleh MI. Clinical Predictors Associated With Warfarin Sensitivity. Am J Ther. 2016 Nov/Dec;23(6):e1690-e1694. doi: 10.1097/MJT.0000000000000248.
- Scott SA, Patel M, Martis S, Lubitz SA, van der Zee S, Yoo C, Edelmann L, Halperin JL, Desnick RJ. Copy number variation and warfarin dosing: evaluation of CYP2C9, VKORC1, CYP4F2, GGCX and CALU. Pharmacogenomics. 2012 Feb;13(3):297-307. doi: 10.2217/pgs.11.156. Epub 2011 Dec 21.
- van der Zee SA, Halperin JL. Anticoagulant therapy: warfarin sensitivity genotyping closer to clinical practice. Nat Rev Cardiol. 2010 Oct;7(10):549-50. doi: 10.1038/nrcardio.2010.126. No abstract available.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

